Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$24.5M
Prescriptions
1,875
$13,052.38 per claim
Patients
536
265 prescribers
Total spending, 2024
$24.5M
$45,658.99 per patient
Medicare prescription drug plans paid $24.5M for Opsynvi in 2024, for 1,875 prescriptions and refills to 536 patients. The average cost per claim was $13,052.38.
California had the highest Medicare cost for Opsynvi in 2024: $2.3M for 173 claims, followed by Texas ($1.9M).
Jean M Elwing, pulmonary disease in Cincinnati, OH, had the highest Medicare cost for Opsynvi in 2024: 85 claims costing $1.1M.
Opsynvi is made by Johnson & Johnson (JNJ), listed in the Medicare spending data as Actelion Pharma.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Jean M Elwing Cincinnati, OH | Pulmonary Disease | 85 | 24 | $1.1M |
| Harrison W Farber Boston, MA | Pulmonary Disease | 68 | 13 | $873K |
| Kimberly C Thompson |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2024 | 265 | 1,875 | 536 | $24.5M |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Actelion Pharma JNJ |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Nurse Practitioner |
| 43 |
| 11 |
| $545K |
| John W McConnell Louisville, KY | Pulmonary Disease | 41 | Under 11 | $525K |
| Akshay Muralidhar Scottsdale, AZ | Critical Care (Intensivists) | 37 | Under 11 | $471K |
| Ricardo Restrepo-Jaramillo Tampa, FL | Pulmonary Disease | 32 | Under 11 | $399K |
| Michael Scharf Philadelphia, PA | Pulmonary Disease | 31 | Under 11 | $398K |
| Alvaro U Aranda- Rodriguez Guaynabo, PR | Pulmonary Disease | 30 | Under 11 | $379K |
| Victor J Test Lubbock, TX | Pulmonary Disease | 29 | Under 11 | $377K |
| Tapas Bandyopadhyay West Hartford, CT | Pulmonary Disease | 27 | Under 11 | $348K |
| Naomi G Habib Phoenix, AZ | Pulmonary Disease | 26 | Under 11 | $332K |
| Therese J Sargent Phoenix, AZ | Nurse Practitioner | 26 | Under 11 | $332K |
| Andy D Tran Fullerton, CA | Pulmonary Disease | 22 | Under 11 | $319K |
| Anjali Vaidya Philadelphia, PA | Advanced Heart Failure and Transplant Cardiology | 25 | Under 11 | $316K |
| Diane L Brackin Fishers, IN | Nurse Practitioner | 22 | Under 11 | $280K |
| Samuel A Allen Troy, MI | Pulmonary Disease | 21 | Under 11 | $272K |
| Ronald J Oudiz Torrance, CA | Cardiology | 15 | Under 11 | $271K |
| Raj D Parikh Hartford, CT | Pulmonary Disease | 21 | 11 | $270K |
| Karla J Cruz Morel Columbia, SC | Pulmonary Disease | 21 | Under 11 | $269K |
| Joseph P Stevenson Reno, NV | Cardiology | 21 | Under 11 | $266K |
| Katherine E Thompson Little Rock, AR | Nurse Practitioner | 21 | Under 11 | $261K |
| Vallerie V McLaughlin Ann Arbor, MI | Cardiology | 20 | Under 11 | $253K |
| Mohammad A Sheatt Cincinnati, OH | Pulmonary Disease | 19 | Under 11 | $239K |
| Senthil Anand New Orleans, LA | Internal Medicine | 18 | Under 11 | $233K |
| Mrinalini Krishnan Philadelphia, PA | Advanced Heart Failure and Transplant Cardiology | 17 | Under 11 | $220K |
| 1,875 |
| $24.5M |